Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Rizzieri

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Advances in Radiation Oncology|July 26, 2017
Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicitySarah J Stephens, Samantha Thomas, David A Rizzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2004
Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimensNelson J Chao, Liang-Piu Koh, Gwynn D Long, et al.
Clinical Lymphoma|October 15, 2003
Rituximab in lymphocyte predominance Hodgkin's disease: a case seriesValerie K Ibom, Robert G Prosnitz, Jerald Z Gong, et al.
Cytokine|July 2, 2002
Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSFCristina Gasparetto, Maura Gasparetto, Michael Morse, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cellsNelson J Chao, Cong X Liu, Barbara Rooney, et al.
Leukemia & Lymphoma|October 1, 2005
Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activityDavid A Rizzieri, Martha Wadleigh, Carol J Wikstrand, et al.
Leukemia & Lymphoma|June 21, 2022
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)James A Davis, David A Rizzieri, Andrew A Lane, et al.
Bone Marrow Transplantation|July 21, 2025
Correction: High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myelomaDharshan Sivaraj, Wendi Bacon, Gwynn D Long, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factorsChris R Kelsey, Mitchell E Horwitz, Junzo P Chino, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2013
Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cellsManabu Kurokawa, Takahiro Ito, Chih-Sheng Yang, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Advances in Radiation Oncology|July 26, 2017
Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicitySarah J Stephens, Samantha Thomas, David A Rizzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2004
Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimensNelson J Chao, Liang-Piu Koh, Gwynn D Long, et al.
Clinical Lymphoma|October 15, 2003
Rituximab in lymphocyte predominance Hodgkin's disease: a case seriesValerie K Ibom, Robert G Prosnitz, Jerald Z Gong, et al.
Cytokine|July 2, 2002
Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSFCristina Gasparetto, Maura Gasparetto, Michael Morse, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cellsNelson J Chao, Cong X Liu, Barbara Rooney, et al.
Leukemia & Lymphoma|October 1, 2005
Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activityDavid A Rizzieri, Martha Wadleigh, Carol J Wikstrand, et al.
Leukemia & Lymphoma|June 21, 2022
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)James A Davis, David A Rizzieri, Andrew A Lane, et al.
Bone Marrow Transplantation|July 21, 2025
Correction: High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myelomaDharshan Sivaraj, Wendi Bacon, Gwynn D Long, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factorsChris R Kelsey, Mitchell E Horwitz, Junzo P Chino, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2013
Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cellsManabu Kurokawa, Takahiro Ito, Chih-Sheng Yang, et al.
Pageof 14